CNBX - Cannabics Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 537.65M
Enterprise Value 331.27M
Trailing P/E 23.33
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3,263.29
Price/Book (mrq)2.06
Enterprise Value/Revenue 32,710.45
Enterprise Value/EBITDA 6-10.60

Trading Information

Stock Price History

Beta (3Y Monthly) -3.40
52-Week Change 3-71.17%
S&P500 52-Week Change 37.14%
52 Week High 31.3500
52 Week Low 30.2700
50-Day Moving Average 30.3131
200-Day Moving Average 30.3613

Share Statistics

Avg Vol (3 month) 390.37k
Avg Vol (10 day) 369.7k
Shares Outstanding 5134.46M
Float 46.17M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 30, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug 31, 2018
Most Recent Quarter (mrq)Feb 28, 2019

Profitability

Profit Margin 12,738.55%
Operating Margin (ttm)-26,997.21%

Management Effectiveness

Return on Assets (ttm)-17.64%
Return on Equity (ttm)13.85%

Income Statement

Revenue (ttm)11.54k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)20.10%
Gross Profit (ttm)9.6k
EBITDA -2.95M
Net Income Avi to Common (ttm)1.47M
Diluted EPS (ttm)0.0120
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.17M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)15.80
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-2.49M
Levered Free Cash Flow (ttm)-2.24M